drugset / Trial / NCT00669864
Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This trial is conducted in Asia. This single arm trial aims to evaluate the blood glucose control with twice daily biphasic insulin aspart 30 in combination with metformin in Chinese subjects with type 2 diabetes inadequately controlled with once or twice daily basal insulin.
Timeline
- Start
- 2007-11
- Primary completion
- 2009-04
- Completion
- 2009-04
Outcome
Met primary endpoint
registry analysis (superiority or other test); BIAsp 30-30; p <0.0001; Estimated mean -1.303 (95% CI -1.414 to -1.192); t-test, 1 sided; NCT00669864 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 1000 mg | Oral |
| Subject | Metformin | Small molecule | 2000 mg | Oral |
| Subject | biphasic insulin aspart 30 | Protein / enzyme biologic | — | Subcutaneous |